Cell and tissue regeneration involves cell proliferation driven by growth factors and the development of mature cells from stem cells. There are three types of tissues based on their proliferative capacity: labile tissues which continuously divide, stable tissues which have limited proliferation, and permanent tissues which do not regenerate. Liver regeneration is remarkable, with up to 90% resection compensated by hepatocyte proliferation induced by cytokines and growth factors. When hepatocytes are impaired, liver progenitor cells contribute to repopulation.
TISSUE DEVELOPMENT WITH TISSUE ENGINEERING APPROACHFelix Obi
Tissue Engineering is the development and practice of combining scaffolds, cells, and suitable biochemical factors (regulatory factors or Signals) into functional tissues. The goal of tissue engineering is to assemble functional constructs that restore, maintain, or improve damaged tissues or whole organs.
Cells are the building blocks of tissue, and tissues are the basic unit of function in the body. Generally, groups of cells make and secrete their own support structures, called extracellular matrix. This matrix, or scaffold, does more than just support the cells; it also acts as a relay station for various signaling molecules. Thus, cells receive messages from many sources that become available from the local environment. Each signal can start a chain of responses that determine what happens to the cell. By understanding how individual cells respond to signals, interact with their environment, and organize into tissues and organisms, Tissue Engineers are now able to manipulate these processes to amend damaged tissues or even create new ones.
TISSUE DEVELOPMENT WITH TISSUE ENGINEERING APPROACHFelix Obi
Tissue Engineering is the development and practice of combining scaffolds, cells, and suitable biochemical factors (regulatory factors or Signals) into functional tissues. The goal of tissue engineering is to assemble functional constructs that restore, maintain, or improve damaged tissues or whole organs.
Cells are the building blocks of tissue, and tissues are the basic unit of function in the body. Generally, groups of cells make and secrete their own support structures, called extracellular matrix. This matrix, or scaffold, does more than just support the cells; it also acts as a relay station for various signaling molecules. Thus, cells receive messages from many sources that become available from the local environment. Each signal can start a chain of responses that determine what happens to the cell. By understanding how individual cells respond to signals, interact with their environment, and organize into tissues and organisms, Tissue Engineers are now able to manipulate these processes to amend damaged tissues or even create new ones.
What are stem cells? This presentation provides an overview of multiple different stem cells including embryonic stem cells, mesenchymal stem cells, cancer stem cells, induced pluripotent stem cells, hematopoietic stem cells and neural stem cells.
regeneration
Proliferative Capacities of Tissues
Stem Cells
REPAIR BY CONNECTIVE TISSUE
Angiogenesis
Migration of Fibroblasts and ECM Deposition (Scar Formation)
PATHOLOGIC ASPECTS OF REPAIR
The cell proliferation will generally decrease with the differentiation of cells, and most cells in adult animals are blocked in the G 0 phase of the cell cycle.
https://www.creative-bioarray.com/Services/cell-proliferation-assay-services.htm
Extra cellular matrix is recently being explored in connection with cancer , metastases and autoimmune disorders. It is prepared for the benefit of both UG and PG medical and dental students.
What are stem cells? This presentation provides an overview of multiple different stem cells including embryonic stem cells, mesenchymal stem cells, cancer stem cells, induced pluripotent stem cells, hematopoietic stem cells and neural stem cells.
regeneration
Proliferative Capacities of Tissues
Stem Cells
REPAIR BY CONNECTIVE TISSUE
Angiogenesis
Migration of Fibroblasts and ECM Deposition (Scar Formation)
PATHOLOGIC ASPECTS OF REPAIR
The cell proliferation will generally decrease with the differentiation of cells, and most cells in adult animals are blocked in the G 0 phase of the cell cycle.
https://www.creative-bioarray.com/Services/cell-proliferation-assay-services.htm
Extra cellular matrix is recently being explored in connection with cancer , metastases and autoimmune disorders. It is prepared for the benefit of both UG and PG medical and dental students.
Wound healing and repair Repair/Healing : restoration of tissue architecture ...MohammadFaisal565026
The regeneration of injured cells and tissues involves cell proliferation, which is driven by growth factors and is critically dependent on the integrity of the extracellular matrix, and by the development of mature cells from stem cells”
Regeneration:
Returning to normal state
Cells having capacity to proliferate
E.g., epithelial cells of skin and intestine
Liver
Scar formation:
Incapable of complete restitution
Supporting tissue severely injured
Fibrosis >> scar formation
“ Acellular connective tissue devoid of inflammatory infiltrate covered by intact epithelium is called scar”
Stem cells are unspecialized cells capable of renewing themselves through cell division, sometimes after long periods of inactivity.
Stem cell therapy is the most advance therapy which use stem cells to treat or prevent a disease or condition.
Properties, types and uses of stem cells are summarized in this presentation.
Stem cells are unspecialized cells capable of renewing themselves through cell division, sometimes after long periods of inactivity.
Stem cell therapy is an advance therapy technique used to treat or prevent a disease or condition using stem cells.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
2. The regeneration of injured cells and tissues
involves
Cell proliferation which is driven by growth
factors and is critically dependent on the
integrity of the extracellular matrix, and by the
development of mature cells from stem cells.
3. Cell Proliferation: Signals and
Control Mechanisms
Several cell types proliferate during tissue repair.
Remnants of the injured tissue (which attempt to
restore normal structure)
Vascular endothelial cells (to create new vessels that
provide the nutrients needed for the repair process),
Fibroblasts (the source of the fibrous tissue that
forms the scar to fill defects that cannot be corrected
by regeneration).
4. The ability of tissues to repair themselves is
determined, in part, by their intrinsic
proliferative capacity.
Tissues of the body are divided into three
groups.
Labile (continuously dividing) tissues
Stable tissues
Permanent tissues
5. Labile (continuously dividing)
tissues.
Continuously being lost and replaced by maturation
from tissue stem cells and by proliferation of mature
cells.
-Hematopoietic cells in the bone marrow
-Majority of surface epithelia
Stratified squamous epithelia of the skin, oral cavity,
vagina, and cervix; the cuboidal epithelia of the ducts
draining exocrine organs (e.g. salivary glands,
pancreas, biliary tract)
Columnar epithelium of the gastrointestinal tract,
uterus, and fallopian tubes; and the transitional
epithelium of the urinary tract.
6. These tissues can readily regenerate after
injury as long as the pool of stem cells is
preserved.
7. Stable tissues
Cells of these tissues are quiescent (in the G0 stage
of the cell cycle) and have only minimal proliferative
activity in their normal state
These cells are capable of dividing in response to
injury or loss of tissue mass.
Stable cells constitute the parenchyma of most solid
tissues, such as liver, kidney, and pancreas.
Include endothelial cells, fibroblasts, and smooth
muscle cells; the proliferation of these cells is
particularly important in wound healing.
8. With the exception of liver, stable tissues have
a limited capacity to regenerate after injury.
9. Permanent tissues
The cells of these tissues are considered to be terminally
differentiated and nonproliferative in postnatal life.
Majority of neurons and cardiac muscle cells.
Thus, injury to the brain or heart is irreversible and results in a
scar, because neurons and cardiac myocytes cannot regenerate.
Limited stem cell replication and differentiation occur
in some areas of the adult brain, and there is some evidence
that heart muscle cells may proliferate after myocardial
necrosis. Nevertheless, whatever proliferative capacity may exist
in these tissues, it is insufficient to produce tissue regeneration
after injury.
10. Skeletal muscle is usually classified as a
permanent tissue, but satellite cells attached to
the endomysial sheath provide some
regenerative capacity for muscle. In permanent
tissues,repair is typically dominated by scar
formation.
11. Cell proliferation is driven by
signals
Provided by growth factors and from the
extracellular matrix
Growth factors are typically produced by cells
near the site of damage
Most important sources of these growth factors
are macrophages
epithelial and stromal cells also produce some of
these factors.
12. Several growth factors bind to ECM proteins and
are displayed at high concentrations
All growth factors activate signaling pathways
that ultimately induce the production of proteins that
are involved in driving cells through the cell cycle and
other proteins that release blocks on the cell cycle
(checkpoints)
13. In addition to responding to growth factors, cells
use integrins to bind to ECM proteins, and signals
from the integrins can also stimulate cell
proliferation.
In the process of regeneration, proliferation of
residual cells is supplemented by development of
mature cells from stem cells.
In adults, the most important stem cells
for regeneration after injury are tissue stem cells
(stem cells live in specialized niches)
14. Injury triggers signals in these niches that activate
quiescent stem cells to proliferate and differentiate into
mature cells that repopulate the injured tissue.
15. Mechanisms of Tissue
Regeneration
Importance of regeneration in the replacement of injured
tissues varies in different types of tissues and with the
severity of injury.
In labile tissues; injured cells are rapidly replaced by
proliferation of residual cells and differentiation of tissue
stem cells provided the underlying basement membrane
is intact. The growth factors involved in these processes
are not defined. Loss of blood cells is corrected by
proliferation of hematopoietic stem cells in the bone
marrow and other tissues, driven by growth factors
called colony-stimulating factors (CSFs), which are
produced in response to the reduced numbers of blood
cells.
16. Tissue regeneration can occur in parenchymal
organs with stable cell populations, but with
the exception of the liver, this is usually a
limited process.
Pancreas, adrenal, thyroid, and lung have
some regenerative capacity. The surgical
removal of a kidney elicits in the remaining
kidney a compensatory response that
consists of both hypertrophy and hyperplasia
of proximal duct cells.
17. The mechanisms underlying this response
are not understood, but likely involve local
production of growth factors and interactions of
cells with the ECM.
The extraordinary capacity of the liver to
regenerate has made it a valuable model for
studying this process, as described below.
18. Restoration of normal tissue structure can
occur only if the residual tissue is structurally
intact, as after partial surgical resection.
If the entire tissue is damaged by infection or
inflammation, regeneration is incomplete and
is accompanied by scarring.
19. Extensive destruction of the liver with collapse of
the reticulin framework, as occurs in a liver
abscess, leads to scar formation even though
the remaining liver cells have the capacity to
regenerate.
20. Liver Regeneration
The human liver has a remarkable capacity to
regenerate, as demonstrated by its growth
after partial hepatectomy, which may be
performed for tumor resection or for living
donor hepatic transplantation.
21. ZEUS
The mythologic image of liver regeneration is
the regrowth of the liver of Prometheus, which
was eaten every day by an eagle sent by
Zeus as punishment for stealing the secret of
fire, and grew back overnight. The reality,
although less dramatic, is still quite
impressive.
22. Regeneration of the liver occurs by two major
mechanisms:proliferation of remaining
hepatocytes and repopulation from progenitor
cells
23. Proliferation of hepatocytes
In humans, resection of up to 90% of the liver
can be corrected by proliferation of the residual
hepatocytes.
This classic model of tissue regeneration has
been used experimentally to study the initiation
and control of the process.
24. Hepatocyte proliferation in the regenerating
liver is triggered by the combined actions of
cytokines and polypeptide growth factors.
25. Priming, phase,
Cytokines such as IL-6 are produced mainly
by Kupffer cells and act on hepatocytes to
make the parenchymal cells competent to
receive and respond to growth factor signals.
26. Growth factor
Growth factors such as HGF and TGF-α,
produced by many cell types, act on primed
hepatocytes to stimulate cell metabolism and
entry of the cells into the cell cycle.
27. Hepatocytes are quiescent cells, it takes them
several hours to enter the cell cycle, progress from
G0 to G1, and reach the S phase of DNA
replication. Almost all hepatocytes replicate during
liver regeneration after partial hepatectomy.
28. The wave of hepatocyte replication is followed by
replication of nonparenchymal cells (Kupffer
cells, endothelial cells, and stellate cells).
During the phase of hepatocyte replication, more
than 70 genes are activated; these include genes
encoding transcription factors, cell cycle
regulators, regulators of energy metabolism, and
many others.
30. Liver regeneration from
progenitor cells
In situations where the proliferative capacity
of hepatocytes is impaired, such as after
chronic liver injury or inflammation, progenitor
cells in the liver contribute to repopulation.
31. In rodents, these progenitor cells have been
called oval cells because of the shape of their
nuclei. Some of these progenitor cells reside
in specialized niches called canals of Hering,
where bile canaliculi connect with larger bile
ducts.
32. References
Robbins & Cotran Pathologic Basis of Disease,
9e (Robbins Pathology) 9th Edition
by Vinay Kumar MBBS MD FRCPath (Author),
Abul K. Abbas MBBS (Author), Jon C. Aster MD
PhD (Author)